Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds German American Q2 EPS $0.81 Down From $0.90 YoY

German American Q2 EPS $0.81 Down From $0.90 YoY

German American (NASDAQ:GABC) reported quarterly earnings of $0.81 per share. This is a 10 percent decrease over earnings of $0.90 per share from the same period last year.

byMichael Horton

July 25, 2022

1 minute read

German American (NASDAQ:GABC) reported quarterly earnings of $0.81 per share. This is a 10 percent decrease over earnings of $0.90 per share from the same period last year.

Mizuho Maintains Buy on EOG Resources, Lowers Price Target to $173

By Benzinga Newsdesk

July 19, 9:43 AM

Mizuho analyst Vincent Lovaglio maintains EOG Resources (NYSE:EOG) with a Buy and lowers the price target from $175 to $173.

EOG

Datadog Upgraded To Buy: Analyst Highlights Positive Customer Feedback And Growth Prospect

By Lekha Gupta

December 7, 4:37 PM

Stifel analyst Brad R.

DDOG

Online Freelance Marketplace Fiverr Posts Q3 Earnings Above Street View; Active Buyers Dip Slightly

By Shivani Kumaresan

November 9, 6:31 AM

Fiverr International Ltd (NYSE: FVRR) reported third-quarter FY23 sales growth of 12.1% year-on-year to $92.53 million,

FVRR

Evercore ISI Group Downgrades Ultragenyx Pharmaceutical to In-Line, Lowers Price Target to $60

By Benzinga Newsdesk

August 1, 5:22 AM

Evercore ISI Group analyst Liisa Bayko downgrades Ultragenyx Pharmaceutical (NASDAQ:RARE) from Outperform to In-Line and lowers the price target from $95 to $60.

RARE

German American Q2 EPS $0.81 Down From $0.90 YoY

Related Posts

Mizuho Maintains Buy on EOG Resources, Lowers Price Target to $173

Datadog Upgraded To Buy: Analyst Highlights Positive Customer Feedback And Growth Prospect

Online Freelance Marketplace Fiverr Posts Q3 Earnings Above Street View; Active Buyers Dip Slightly

Evercore ISI Group Downgrades Ultragenyx Pharmaceutical to In-Line, Lowers Price Target to $60